ESR1 and breast cancer: Most canine patients with mammary tumors express high tissue levels of ERα as well as high serum E2 levels (>35 pg/mL) [19,20], although a negative correlation between ERα expression and histological differentiation is observed, as malignant high-grade canine mammary tumors (CMTs) tend to be ERα-negative [21,22].